Mr. Chair, thank you for the question.
We've been working quite extensively over the last three-plus months on setting the conditions for effective rollout, which started in December. We continue to build this so that we have an effective increase in capacity and an increased ability to deliver and scale up from April onwards, when more vaccines become available, into the millions a week, as well as additional 8° vaccines as they get added.
This week, a culminating event occurred when we had an opportunity to bring together over 170 participants to discuss the level of readiness, and we'll pursue some of that through bilateral engagements in the coming days.